73 related articles for article (PubMed ID: 7763022)
21. Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer.
Arai T; Yasuda Y; Takaya T; Hayakawa K; Toshima S; Shibuya C; Kashiki Y; Yoshimi N; Shibayama M
Cancer Detect Prev; 2000; 24(3):252-7. PubMed ID: 10975287
[TBL] [Abstract][Full Text] [Related]
22. Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line.
Berhane K; Hao XY; Egyházi S; Hansson J; Ringborg U; Mannervik B
Cancer Res; 1993 Sep; 53(18):4257-61. PubMed ID: 8395980
[TBL] [Abstract][Full Text] [Related]
23. [Immunohistochemical investigation on the expression of glutathione S-transferases (GSTS) in lung cancer].
Nie KR; Li CH; Zhu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Jun; 16(3):141-3, 186. PubMed ID: 8242809
[TBL] [Abstract][Full Text] [Related]
24. Placental isoform glutathione S-transferase and P-glycoprotein expression in advanced nonsmall cell lung cancer: association with response to treatment and survival.
Vlachogeorgos GS; Manali ED; Blana E; Legaki S; Karagiannidis N; Polychronopoulos VS; Roussos C
Cancer; 2008 Dec; 114(6):519-26. PubMed ID: 19006072
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of apoptosis is the cause of resistance to doxorubicin in human breast adenocarcinoma cells.
Osmak M; Brozović A; Ambriović-Ristov A; Hadzija M; Pivcević B; Smital T
Neoplasma; 1998; 45(4):223-30. PubMed ID: 9890665
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.
Miyatake K; Gemba K; Ueoka H; Nishii K; Kiura K; Tabata M; Shibayama T; Takigawa N; Kawaraya M; Tanimoto M
Anticancer Res; 2003; 23(3C):2829-36. PubMed ID: 12926120
[TBL] [Abstract][Full Text] [Related]
27. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.
Cheng X; Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Okada M; Terakawa N
Cancer; 1997 Feb; 79(3):521-7. PubMed ID: 9028363
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
Huang J; Tan PH; Thiyagarajan J; Bay BH
Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
[TBL] [Abstract][Full Text] [Related]
29. Role of glutathione S-transferases in the resistance of human colon cancer cell lines to doxorubicin.
Beaumont PO; Moore MJ; Ahmad K; Payne MM; Lee C; Riddick DS
Cancer Res; 1998 Mar; 58(5):947-55. PubMed ID: 9500455
[TBL] [Abstract][Full Text] [Related]
30. [Vascular thickness and cytostatic-resistant bronchial carcinoma].
Volm M; Koomägi R; van Kaick G; Mattern J
Dtsch Med Wochenschr; 1996 Mar; 121(10):291-4. PubMed ID: 8681711
[TBL] [Abstract][Full Text] [Related]
31. Chemoresistance to doxorubicin and cisplatin in a murine cell line. Analysis of P-glycoprotein, topoisomerase II activity, glutathione and related enzymes.
Mestdagh N; Pommery N; Saucier JM; Hecquet B; Fournier C; Slomianny C; Teissier E; Hénichart JP
Anticancer Res; 1994; 14(3A):869-74. PubMed ID: 7915509
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
33. [Expression and significance of MRP, GST-pi, Topo IIalpha, and LRP in gastric carcinoma].
Yu DQ; Yi YF
Ai Zheng; 2003 May; 22(5):496-9. PubMed ID: 12753710
[TBL] [Abstract][Full Text] [Related]
34. Expression of multidrug resistance-related markers in gastric cancer.
Fan K; Fan D; Cheng LF; Li C
Anticancer Res; 2000; 20(6C):4809-14. PubMed ID: 11205224
[TBL] [Abstract][Full Text] [Related]
35. Nuclear morphometry and glutathione S-transferase pi expression in breast cancer.
Huang J; Bay BH; Tan PH
Oncol Rep; 2000; 7(3):609-13. PubMed ID: 10767377
[TBL] [Abstract][Full Text] [Related]
36. [The expression of glutathione S-transferase pi in human ovarian cancer as an indicator of resistance to chemotherapy].
Li L; Yao D; Chen X
Zhonghua Fu Chan Ke Za Zhi; 1998 Feb; 33(2):95-7. PubMed ID: 10682429
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between hMSH2 and FHIT gene expression in non-small cell lung cancer].
Zhu LQ; Diao LM; Chen DJ; Li HG; Liu X; Zou ZY; Li BY; Wang M; Liu MQ
Ai Zheng; 2003 Jun; 22(6):571-4. PubMed ID: 12948402
[TBL] [Abstract][Full Text] [Related]
38. Relationship of DNA ploidy to chemoresistance of tumors as measured by in vitro tests.
Volm M; Efferth T
Cytometry; 1990; 11(3):406-10. PubMed ID: 1971209
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of P-glycoprotein and glutathione S-transferase-pi in resistant non-small cell lung carcinomas of smokers.
Volm M; Mattern J; Samsel B
Br J Cancer; 1991 Oct; 64(4):700-4. PubMed ID: 1680367
[TBL] [Abstract][Full Text] [Related]
40. Chemosensitivity of advanced larynx carcinoma cells in vitro and significance of multidrug resistance markers in these tumors.
Juvekar AS; Amonkar AJ; D'cruz AK; Saikaia T; Pradhan S
Cancer Biother Radiopharm; 1998 Apr; 13(2):81-7. PubMed ID: 10850344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
